The REBLOZEL brand, founded in 2015 (United States), from
126 sister brands
and 17478 competing brands.
REBLOZEL is owned by Celgene, listed on the stock exchange of New York
The sector of REBLOZEL is Drug Manufacturers.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.